市場調查報告書
商品編碼
1494448
北美伴侶動物診斷市場預測至 2030 年 - 區域分析 - 按技術、產品、應用、伴侶動物類型和最終用戶North America Companion Animal Diagnostics Market Forecast to 2030 - Regional Analysis - by Technique, Product, Application, Companion Animal Type, and End User |
2022年北美伴侶動物診斷市場估值為11.931億美元,預計2030年將達23.619億美元;預計2022年至2030年複合年成長率為8.9%。
技術進步推動北美伴侶動物診斷市場
支持疾病早期發現的診斷技術的改進有助於寵物慢性病治療取得更大成功。近年來,動物診斷技術的進步導致了更準確、更靈敏和更特異的診斷測試的發展。新一代定序 (NGS) 技術的使用是伴侶動物診斷領域的重大進步。 NGS 是一種強大的工具,可以快速、同時分析多個基因,從而能夠識別可能與特定疾病相關的基因突變。 NGS 也為癌症、遺傳性疾病和其他類似疾病提供了更靈敏、更特異的診斷測試。例如,MiDOG, LLC 推出了一種新的一體化微生物測試。該測試使用新一代 DNA 定序 (NGS) 來發現犬類樣本上的各種細菌(厭氧和需氧)、真菌和抗生素抗藥性。
此外,人工智慧 (AI) 和機器學習在伴侶動物診斷中的使用增加。人工智慧驅動的演算法可以在診斷中實施,以分析大量資料以識別模式並做出預測,這有助於提高診斷測試的準確性和效率。
北美伴侶動物診斷市場概述
北美伴侶動物診斷市場分為美國、加拿大和墨西哥。該地區市場的成長是由於政府對獸醫研究和開發活動的支持不斷增加、技術不斷進步導致各種市場整合以及北美各國對寵物的採用不斷增加。此外,伴侶動物診斷市場中各種市場領導者的出現預計將對預測期內的市場成長產生積極影響。
在美國,特定的獸醫診斷受到監管並依賴美國農業部獸醫生物製品中心 (USDA-CVB) 的批准。這些涉及獸醫診斷試劑盒,旨在診斷接受治療的動物的病原體。 USDA-CVB 是用於檢測貓白血病病毒 (FeLV)、犬小病毒、犬心絲蟲和其他病毒的即時診斷。國家獸醫服務實驗室為動物提供診斷服務,並提供圍繞國內外動物疾病診斷的廣泛診斷服務和資訊。該實驗室也參與支持疾病控制和根除計畫。它生產診斷測試試劑並提供培訓和實驗室認證。同樣,還有隸屬於美國獸醫實驗室診斷師協會的其他私人實驗室。例如,威斯康辛州獸醫診斷實驗室為生產、伴侶和外來動物產業提供廣泛的診斷服務。
北美伴侶動物診斷市場收入及 2030 年預測(百萬美元)
北美伴侶動物診斷市場細分
北美伴侶動物診斷市場根據技術、產品、應用、伴侶動物類型、最終用戶和國家進行細分。
根據技術,北美伴侶動物診斷市場分為免疫診斷、臨床生物化學、分子診斷、尿液分析、血液學等。免疫診斷部分進一步分為橫向測定、ELISA 測試、過敏原特異性免疫診斷測試和免疫分析儀。臨床生化部分進一步分為臨床生化分析、血糖監測及血液氣體電解質分析。此外,生物化學部分分為PCR、微陣列等。
依產品分類,北美伴侶動物診斷市場分為儀器和消耗品。 2022 年,儀器儀表領域將佔據更大的佔有率。
在應用方面,北美伴侶動物診斷市場分為細菌學、臨床病理學、病毒學、寄生蟲學等。 2022年,臨床病理學領域佔最大佔有率。
根據伴侶動物類型,北美伴侶動物診斷市場分為狗、貓、馬等。 2022 年,狗類細分市場佔據最大佔有率。
依最終用戶分類,北美伴侶動物診斷市場分為診斷實驗室、獸醫醫院和診所、研究機構等。 2022 年,獸醫院和診所佔最大佔有率。
按國家/地區分類,北美伴侶動物診斷市場分為美國、加拿大和墨西哥。 2022 年,美國將主導北美伴侶動物診斷市場。
Heska Corp、i-SENS Inc、Immunology Consultants Laboratory Inc、Zoetis Inc 和 Elabscience Biotechnology Inc 是北美伴侶動物診斷市場上的一些領先公司。
The North America companion animal diagnostics market was valued at US$ 1,193.10 million in 2022 and is expected to reach US$ 2,361.90 million by 2030; it is estimated to register a CAGR of 8.9% from 2022 to 2030.
Technological Advancements Fuel North America Companion Animal Diagnostics Market
Improvements in diagnostic technologies to support the early detection of diseases have contributed to the greater success of treatment of chronic diseases in pets. In recent years, technological advancements in animal diagnostics have resulted in the development of more accurate, sensitive, and specific diagnostic tests. The use of next-generation sequencing (NGS) technology is a significant advancement in companion animal diagnostics. NGS is a powerful tool that allows for the rapid and simultaneous analysis of multiple genes, enabling the identification of genetic mutations that may be linked to a specific disease. NGS has also unlocked more sensitive and specific diagnostic tests for cancer, hereditary diseases, and other similar diseases. For example, A new All-in-One Microbial Test has been introduced by MiDOG, LLC. The test finds every type of bacteria, both anaerobic and aerobic, fungus, and antibiotic resistance on canine specimens using next-generation DNA sequencing (NGS).
Moreover, there has been an increase in the use of artificial intelligence (AI) and machine learning in companion animal diagnostics. AI-powered algorithms can be implemented in diagnostics to analyze large volumes of data to identify patterns and make predictions, which can help improve the accuracy and efficiency of diagnostic tests.
North America Companion Animal Diagnostics Market Overview
The North America companion animal diagnostics market is divided into the US, Canada, and Mexico. The growth of the market in the region is due to rising government support for research and development activities in veterinary medicine, growing technological advancements that are resulting in various market consolidations, and rising adoption of pet animals across countries in North America. In addition, the presence of various market leaders in the companion animal diagnostics market is projected to influence the market growth positively during the forecast period.
In the US, specific veterinary diagnostics are regulated and dependent on the US Department of Agriculture-Center for Veterinary Biologics (USDA-CVB) for approval. These involve veterinary diagnostic kits intended to diagnose pathogens in animals undergoing treatment. USDA-CVB are point-of-care diagnostics for testing feline leukemia virus (FeLV), canine parvovirus, canine heartworm, and other viruses. The National Veterinary Services Laboratories provide diagnostics services for animals, and it offers a wide range of diagnostic services and information centered around the diagnosis of domestic and foreign animal diseases. The laboratory is also involved in the support of disease control and eradication programs. It produces reagents for diagnostic testing and offers training and laboratory certification. Similarly, there are presence other private laboratories affiliated to the American Association of Veterinary Laboratory Diagnosticians. For instance, the Wisconsin Veterinary Diagnostic Laboratory offers a broad range of diagnostic services to the production, companion, and exotic animal industries.
North America Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Million)
North America Companion Animal Diagnostics Market Segmentation
The North America companion animal diagnostics market is segmented based on technique, product, application, companion animal type, end user, and country.
Based on technique, the North America companion animal diagnostics market is segmented into immunodiagnostics, clinical biochemistry, molecular diagnostics, urinalysis, hematology, and others. Immunodiagnostics segment is further categorized into lateral assays, ELISA tests, allergen-specific immunodiagnostics tests, and immunoassay analyzers. Clinical biochemistry segment is further categorized into clinical chemistry analysis, glucose monitoring, and blood gas electrolyte analysis. Also, biochemistry segment is categorized into PCR, microarray, and others.
By product, the North America companion animal diagnostics market is bifurcated into instruments and consumables. The instruments segment held a larger share in 2022.
In terms of application, the North America companion animal diagnostics market is segmented into bacteriology, clinical pathology, virology, parasitology, and others. The clinical pathology segment held the largest share in 2022.
Based on companion animal type, the North America companion animal diagnostics market is segmented into dogs, cats, horses, and others. The dogs segment held the largest share in 2022.
By end user, the North America companion animal diagnostics market is segmented into diagnostic laboratories, veterinary hospitals and clinics, research institutes, and others. The veterinary hospitals and clinics segment held the largest share in 2022.
Based on country, the North America companion animal diagnostics market is categorized into US, Canada, and Mexico. The US dominated the North America companion animal diagnostics market in 2022.
Heska Corp, i-SENS Inc, Immunology Consultants Laboratory Inc, Zoetis Inc, and Elabscience Biotechnology Inc are some of the leading companies operating in the North America companion animal diagnostics market.